A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents With Acute Uncomplicated Influenza.

Trial Profile

A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents With Acute Uncomplicated Influenza.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Jul 2014

At a glance

  • Drugs Nitazoxanide (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors Romark Laboratories
  • Most Recent Events

    • 23 Oct 2011 Results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
    • 22 Oct 2011 Results will be presented at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA), according to a Romark Laboratories media release. Results were also reported in the media release.
    • 22 Oct 2011 Primary endpoint 'Time-to-resolution-of-symptoms' has been met, according to a Romark Laboratories media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top